Literature DB >> 12591933

A residue in the S2 subsite controls substrate selectivity of matrix metalloproteinase-2 and matrix metalloproteinase-9.

Emily I Chen1, Weizhong Li, Adam Godzik, Eric W Howard, Jeffrey W Smith.   

Abstract

Matrix metalloproteinase (MMP)-2 and MMP-9 are closely related metalloproteinases that are implicated in angiogenesis. The two proteins have a similar domain structure and highly homologous catalytic domains, making them an excellent comparative model for understanding the structural basis of substrate recognition by the MMP family. Although the two MMPs exhibit some overlap in substrate recognition, our recent work showed that MMP-2 can cleave a set of peptide substrates that are only poorly recognized by MMP-9 (Chen, E. I., Kridel, S. J., Howard, E. W., Li, W., Godzik, A., and Smith, J. W. (2002) J. Biol. Chem. 277, 4485-4491). Mutations at the P(2) position of these peptide substrates dramatically reduced their selectivity for MMP-2. Inspection of the corresponding S(2) pocket of the substrate-binding cleft of the protease reveals that MMP-9 contains an Asp, whereas MMP-2 contains Glu. Here, we test the hypothesis that this conservative substitution has a role in substrate selectivity. Mutation of Glu(412) in MMP-2 to Asp significantly reduced the hydrolysis of selective substrates, with only a minor effect on hydrolysis of non-selective substrates. The predominant effect of the mutation is at the level of k(cat), or turnover rate, with reductions reaching as high as 37-fold. The residues that occupy this position in other MMPs are highly variable, providing a potential structural basis for substrate recognition across the MMP family.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591933     DOI: 10.1074/jbc.M210324200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.

Authors:  Sergey A Shiryaev; Piotr Cieplak; Alexander E Aleshin; Qing Sun; Wenhong Zhu; Khatereh Motamedchaboki; Alexander Sloutsky; Alex Y Strongin
Journal:  FEBS J       Date:  2011-08-08       Impact factor: 5.542

2.  2-Photon Characterization of Optical Proteolytic Beacons for Imaging Changes in Matrix-Metalloprotease Activity in a Mouse Model of Aneurysm.

Authors:  Darren G Haskett; David Maestas; Stephen J Howerton; Tyler Smith; D Catalina Ardila; Tom Doetschman; Urs Utzinger; Dominic McGrath; J Oliver McIntyre; Jonathan P Vande Geest
Journal:  Microsc Microanal       Date:  2016-02-23       Impact factor: 4.127

3.  Basis for substrate recognition and distinction by matrix metalloproteinases.

Authors:  Boris I Ratnikov; Piotr Cieplak; Kosi Gramatikoff; James Pierce; Alexey Eroshkin; Yoshinobu Igarashi; Marat Kazanov; Qing Sun; Adam Godzik; Andrei Osterman; Boguslaw Stec; Alex Strongin; Jeffrey W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

Review 4.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

5.  New tools for the quantitative assessment of prodrug delivery and neurotoxicity.

Authors:  Lynn E Samuelson; Randy L Scherer; Michael N VanSaun; Kang-Hsien Fan; E Ashley Dozier; Kathy J Carter; Tatsuki Koyama; Yu Shyr; Michael Aschner; Gregg D Stanwood; Darryl J Bornhop; Lynn M Matrisian; J Oliver McIntyre
Journal:  Neurotoxicology       Date:  2015-02-27       Impact factor: 4.294

6.  Biochemical characterization of the cellular glycosylphosphatidylinositol-linked membrane type-6 matrix metalloproteinase.

Authors:  Ilian A Radichev; Albert G Remacle; Sergey A Shiryaev; Angela N Purves; Sherida L Johnson; Maurizio Pellecchia; Alex Y Strongin
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

7.  Matrix metalloproteinase-14 both sheds cell surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages and governs the response to peripheral nerve injury.

Authors:  Tasuku Nishihara; Albert G Remacle; Mila Angert; Igor Shubayev; Sergey A Shiryaev; Huaqing Liu; Jennifer Dolkas; Andrei V Chernov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

8.  Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.

Authors:  Asmaa B Hamze; Shuo Wei; Harinath Bahudhanapati; Smitha Kota; K Ravi Acharya; Keith Brew
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

9.  Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.

Authors:  Albert G Remacle; Sergey A Shiryaev; Vladislav S Golubkov; John N Freskos; Michael A Brown; Amolkumar S Karwa; Arati D Naik; Carol P Howard; Carolyn J Sympson; Alex Y Strongin
Journal:  J Biol Chem       Date:  2013-06-03       Impact factor: 5.157

10.  Synthesis and in vitro efficacy of MMP9-activated NanoDendrons.

Authors:  Lynn E Samuelson; Randy L Scherer; Lynn M Matrisian; J Oliver McIntyre; Darryl J Bornhop
Journal:  Mol Pharm       Date:  2013-06-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.